Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureHA is a life science company specializing in the development and commercialization of high-purity, liquid hyaluronic acid (HA) supplements. The company's flagship product is a science-led oral formulation designed to support joint health and skin hydration by utilizing high molecular weight HA that mimics the body's natural substances. PureHA focuses on the bioavailability and purity of its ingredients, partnering with leading HA manufacturers like Contipro to ensure pharmaceutical-grade quality. Their business model bridges the gap between traditional nutraceuticals and clinical-grade wellness products, targeting consumers seeking evidence-based anti-aging and orthopedic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PureHA Labs.